Imbed Biosciences, Inc. announced that it will receive $3,600,000 in funding on December 14, 2023. The company will issue convertible debt and option, warrant or other Right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,066 JPY | +0.60% | +0.98% | +51.27% |
Apr. 11 | Jefferies Starts Niterra at Hold With 4,700 Yen Price Target | MT |
Apr. 01 | Tranche Update on Niterra Co., Ltd.'s Equity Buyback Plan announced on July 31, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.27% | 6.46B | |
+29.62% | 50.98B | |
+25.77% | 20.39B | |
-20.63% | 19.42B | |
+31.67% | 17.27B | |
+1.48% | 15.84B | |
-18.75% | 13.35B | |
+31.97% | 11.74B | |
+28.58% | 10.66B | |
+30.12% | 10.21B |
- Stock Market
- Equities
- 5334 Stock
- News Niterra Co., Ltd.
- Imbed Biosciences, Inc. announced that it expects to receive funding